| |
| |
|
| Insider
Information: |
Schuth Alexander O. |
| Relationship: |
COFO and Secretary |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
187,341 |
|
|
Indirect Shares
|
523,749 |
|
|
| Direct
Value |
$3,883,579 |
|
|
|
Indirect Value
|
$10,857,317 |
|
|
| Total
Shares |
711,090 |
|
|
| Total
Value |
$14,740,896 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
15
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
13
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -30.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Denali Therapeutics Inc. |
DNLI |
COFO and Secretary |
2024-02-14 |
187,341 |
2024-02-14 |
523,749 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
90 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2020-08-21 |
4 |
D |
$32.88 |
$64,248 |
I/I |
(1,954) |
614,562 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-08-14 |
4 |
AS |
$23.67 |
$65,613 |
I/I |
(2,772) |
518,989 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-08-10 |
4 |
S |
$24.18 |
$68,986 |
I/I |
(2,853) |
521,761 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-04-11 |
4 |
AS |
$27.73 |
$69,658 |
I/I |
(2,512) |
647,589 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-04-09 |
4 |
AS |
$28.17 |
$69,721 |
I/I |
(2,475) |
652,614 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-04-10 |
4 |
AS |
$28.26 |
$71,017 |
I/I |
(2,513) |
650,101 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-01-05 |
4 |
S |
$28.44 |
$74,968 |
I/I |
(2,636) |
497,173 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-01-04 |
4 |
S |
$28.70 |
$83,574 |
D/D |
(2,912) |
149,828 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-01-04 |
4/A |
S |
$28.70 |
$83,574 |
I/I |
(2,912) |
492,309 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2022-08-19 |
4 |
S |
$33.22 |
$85,575 |
I/I |
(2,576) |
467,471 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2022-02-11 |
4 |
S |
$34.68 |
$97,208 |
I/I |
(2,803) |
465,047 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-02-13 |
4 |
S |
$30.09 |
$105,225 |
I/I |
(3,497) |
528,691 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-02-09 |
4 |
S |
$74.66 |
$109,809 |
I/I |
(1,468) |
537,344 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-04-13 |
4 |
AS |
$25.04 |
$122,646 |
I/I |
(4,898) |
528,691 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-08-19 |
4 |
S |
$49.56 |
$126,186 |
I/I |
(2,544) |
484,038 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2022-01-05 |
4 |
S |
$44.77 |
$127,415 |
I/I |
(2,846) |
457,737 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-04-12 |
4 |
AS |
$25.04 |
$127,754 |
I/I |
(5,102) |
528,691 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-09-09 |
4 |
AS |
$18.16 |
$136,200 |
I/I |
(7,500) |
610,089 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-06-10 |
4 |
AS |
$18.77 |
$140,775 |
I/I |
(7,500) |
632,589 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-08-07 |
4 |
AS |
$18.81 |
$141,075 |
I/I |
(7,500) |
617,589 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-07-08 |
4 |
AS |
$20.25 |
$152,135 |
I/I |
(7,500) |
625,089 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2024-01-05 |
4 |
S |
$19.43 |
$193,756 |
I/I |
(9,972) |
539,307 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-02-11 |
4 |
S |
$70.17 |
$214,341 |
I/I |
(3,047) |
541,582 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2019-11-25 |
4 |
AS |
$18.02 |
$254,533 |
I/I |
(14,125) |
584,607 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-05-15 |
4 |
AS |
$28.55 |
$286,044 |
I/I |
(10,000) |
528,691 |
0 |
% |
|
90 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
